Detection of Candida auris increased significantly in the past two years.

Drug-Resistant Candida auris Infection Rates Continue to Rise
Go to source).
Candida auris Poses a Major Health Risk
C. auris poses a serious health risk. Approximately 50% of isolates resist both disinfection and multiple antibiotics. Thus, mortality rates are high when this organism becomes established in the bloodstream. First detected in the United States in 2016, the C. auris infection rate increased 95% by 2021.The BioMérieux researchers analyzed C. auris detection rates in a United States cohort from 2021 to 2023 and found a significant increase in C. auris bloodstream infections in 2023 compared with infections in previous years.
“The study results confirm that we must continue to emphasize public health interventions under the leadership of the Centers for Disease Control and Prevention in order to meet the continuing challenge posed by antimicrobial-resistant C. auris and protect community health,” said presenting author Tristan T. Timbook, Director of Health Economics Outcomes Research, Global Medical Affairs, for bioMérieux. “The near real-time surveillance provided by TREND and the BIOFIRE BCID2 panel represent important tools for monitoring trends in C. auris infection.”
Reference:
- Drug-Resistant Candida auris Infection Rates Continue to Rise - (https://asm.org/Press-Releases/2023/June/Drug-Resistant-Candida-auris-Infection-Rates-Conti)
Source-Eurekalert
MEDINDIA










